Cargando…
Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering
A major limitation of clinically used cancer drugs is the lack of specificity resulting in toxicity. To address this, we performed a phenotypically-driven screen to identify optimal multidrug combinations acting with high efficacy and selectivity in clear cell renal cell carcinoma (ccRCC). The searc...
Autores principales: | Weiss, Andrea, Le Roux-Bourdieu, Morgan, Zoetemelk, Marloes, Ramzy, George M., Rausch, Magdalena, Harry, Daniela, Miljkovic-Licina, Marijana, Falamaki, Katayoun, Wehrle-Haller, Bernard, Meraldi, Patrick, Nowak-Sliwinska, Patrycja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826636/ https://www.ncbi.nlm.nih.gov/pubmed/31652588 http://dx.doi.org/10.3390/cancers11101612 |
Ejemplares similares
-
Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment
por: Zoetemelk, Marloes, et al.
Publicado: (2020) -
Forcing dividing cancer cells to die; low‐dose drug combinations to prevent spindle pole clustering
por: Ducrey, Eloise, et al.
Publicado: (2021) -
Anti-angiogenic effects of crenolanib are mediated by mitotic modulation independently of PDGFR expression
por: Berndsen, Robert H., et al.
Publicado: (2019) -
Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma
por: Zoetemelk, Marloes, et al.
Publicado: (2019) -
Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance
por: Rausch, Magdalena, et al.
Publicado: (2020)